HEMOGENYX
HemoGenyx LLC, a privately held biopharmaceutical company, is developing a revolutionary new treatment for blood diseases, such as leukemia and lymphoma. They leverage a special class of cells, which can generate cancer-free blood stem cells. Their therapy will dramatically increase the efficacy of bone marrow transplants and eliminate the need for donors.
HEMOGENYX
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2013-01-01
Address:
Buffalo, New York, United States
Country:
United States
Website Url:
http://www.hemogenyx.com
Total Employee:
11+
Status:
Active
Contact:
+1 (347) 735-8380
Email Addresses:
[email protected]
Total Funding:
61.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics Wordpress Plugins
Current Advisors List
Jeffrey Fidelman Advisor @ HemoGenyx Advisor 2015-01-01
Current Employees Featured
Vladislav Sandler
Vladislav Sandler CEO @ HemoGenyx CEO 2017-10-01
Vladislav Sandler
Vladislav Sandler CEO @ HemoGenyx CEO 2017-10-01
Vladislav Sandler
Vladislav Sandler Co-Founder, CEO @ HemoGenyx Co-Founder, CEO 2013-12-01
Founder
Vladislav Sandler
Stock Details
Company's stock symbol is LSE:HEMO
Investors List
Mint Capital
Mint Capital investment in Post-IPO Debt - HemoGenyx
43North
43North investment in Seed Round - HemoGenyx
Official Site Inspections
http://www.hemogenyx.com
- Host name: li677-21.members.linode.com
- IP address: 88.80.184.21
- Location: London United Kingdom
- Latitude: 51.5164
- Longitude: -0.093
- Timezone: Europe/London
- Postal: EC2V
Loading ...